Ketogenic Diet and β‐Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti‐PD‐L1 Immunotherapy Efficacy
Yuan Zeng, Gangli Gu, Lin Yang, Bohao Fan, Haochen Cui, Lei Yan, Zhao Liu · 2026
Read Ketogenic Diet and β‐Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti‐PD‐L1 Immunotherapy Efficacy by Yuan Zeng, Gangli Gu, Lin Yang, Bohao Fan, Haochen Cui, Lei Yan, Zhao Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13394661.txt.
Description
Yuan Zeng and co-authors report, in 2026, that a high-fat, low-carb diet can help immune drugs fight bladder cancer. Such diets raise a fuel named beta-hydroxybutyrate in the blood. In mice with bladder tumours, the diet slowed growth and raised levels of a target called PD-L1 on tumour cells. Giving the fuel alone, with a normal diet, copied the diet effect.
The fuel raised harmful oxygen radicals inside cancer cells and drained their energy, pushing them to die. It also drew more killer immune cells into tumours. Paired with a PD-L1 blocker, results improved further. The authors back trials of diet as a helper for immune therapy.
Catalog record
| CREATOR | Yuan Zeng, Gangli Gu, Lin Yang, Bohao Fan, Haochen Cui, Lei Yan, Zhao Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52144 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |